Adicet Bio, Inc. operates as a clinical-stage bio-pharmaceutical company. The Company designs and develops of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio serves customers worldwide.

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans (PDF)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Adicet Bio (ACET US)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans (PDF)

Annual report pursuant to Section 13 or 15(d) (PDF)

Current report pursuant to Section 13 or 15(d) (PDF)

US SEC Form SC 13G for Adicet Bio Inc

Current report pursuant to Section 13 or 15(d) (PDF)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)